These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33450997)

  • 1. Mitophagy Modulation, a New Player in the Race against ALS.
    Madruga E; Maestro I; Martínez A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations.
    Maestro I; de la Ballina LR; Porras G; Corrochano S; De Lago E; Simonsen A; Boya P; Martinez A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
    Muyderman H; Chen T
    Br J Pharmacol; 2014 Apr; 171(8):2191-205. PubMed ID: 24148000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Jankovic M; Novakovic I; Gamil Anwar Dawod P; Gamil Anwar Dawod A; Drinic A; Abdel Motaleb FI; Ducic S; Nikolic D
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin.
    Tak YJ; Park JH; Rhim H; Kang S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.
    Moore AS; Holzbaur EL
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3349-58. PubMed ID: 27247382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.
    Araujo BG; Souza E Silva LF; de Barros Torresi JL; Siena A; Valerio BCO; Brito MD; Rosenstock TR
    Mol Neurobiol; 2020 Dec; 57(12):5084-5102. PubMed ID: 32840822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
    Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
    Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
    Shi P; Wei Y; Zhang J; Gal J; Zhu H
    J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways to mitochondrial dysfunction in ALS pathogenesis.
    Carrì MT; D'Ambrosi N; Cozzolino M
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1187-1193. PubMed ID: 27416757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.
    Gil-Bea FJ; Aldanondo G; Lasa-Fernández H; López de Munain A; Vallejo-Illarramendi A
    Expert Rev Mol Med; 2017 Jun; 19():e7. PubMed ID: 28597807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Releasing Syntaphilin Removes Stressed Mitochondria from Axons Independent of Mitophagy under Pathophysiological Conditions.
    Lin MY; Cheng XT; Tammineni P; Xie Y; Zhou B; Cai Q; Sheng ZH
    Neuron; 2017 May; 94(3):595-610.e6. PubMed ID: 28472658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mitochondria in amyotrophic lateral sclerosis.
    Smith EF; Shaw PJ; De Vos KJ
    Neurosci Lett; 2019 Sep; 710():132933. PubMed ID: 28669745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria.
    Wong YC; Holzbaur EL
    Autophagy; 2015; 11(2):422-4. PubMed ID: 25801386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.
    Kamat PK; Kalani A; Kyles P; Tyagi SC; Tyagi N
    Cell Biochem Biophys; 2014 Nov; 70(2):707-19. PubMed ID: 24807843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal degradation of depolarized mitochondria is rate-limiting in OPTN-dependent neuronal mitophagy.
    Evans CS; Holzbaur ELF
    Autophagy; 2020 May; 16(5):962-964. PubMed ID: 32131674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
    Deng Z; Sheehan P; Chen S; Yue Z
    Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.
    Perera ND; Sheean RK; Lau CL; Shin YS; Beart PM; Horne MK; Turner BJ
    Autophagy; 2018; 14(3):534-551. PubMed ID: 28980850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Division Inhibitor 1 Prevents Early-Stage Induction of Mitophagy and Accelerated Cell Death in a Rat Model of Moderate Controlled Cortical Impact Brain Injury.
    Niu F; Dong J; Xu X; Zhang B; Liu B
    World Neurosurg; 2019 Feb; 122():e1090-e1101. PubMed ID: 30439527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics.
    Chen W; Guo L; Li M; Wei C; Li S; Xu R
    Brain Res; 2022 Jul; 1786():147904. PubMed ID: 35390335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.